VA’s US$1.6 Billion AI Deal Could Be A Game Changer For Salesforce (CRM)

Salesforce.com, inc.

Salesforce.com, inc.

CRM

0.00

  • Earlier this month, the U.S. Department of Veterans Affairs awarded Salesforce, via its distribution network, a three-year Agentic Enterprise License Agreement with a total contract ceiling of US$1.60 billion to expand Missionforce, Agentforce, Slack, MuleSoft, Tableau, and Data 360 across its nationwide care network.
  • The move shows how one of the largest federal healthcare systems is treating Salesforce’s AI agents and unified data stack as core infrastructure to modernize care coordination for around 17 million Veterans.
  • Next, we’ll examine how this large, AI-focused VA contract shapes Salesforce’s investment narrative, especially around Missionforce’s role in government modernisation.

Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

What Is Salesforce's Investment Narrative?

For Salesforce to make sense as a long‑term holding, an investor has to believe its pivot toward AI agents and unified data remains central to how large organizations run customer and citizen services, and that the current valuation gap to consensus reflects execution worries more than business decay. The US$1.60 billion VA Agentic Enterprise License Agreement looks material to that thesis: it validates Missionforce and Agentforce as core infrastructure in one of the most demanding public healthcare environments, reinforces Salesforce’s public‑sector track record, and arrives just as the market has been questioning its AI monetisation, slower forecast growth and high debt load. In the near term, the VA deal adds a credible AI revenue and reference win to Salesforce’s existing earnings and margin story, but it sits alongside risks around government project delivery, index exclusion, and elevated expectations embedded in both community and analyst fair values.

However, investors also need to weigh how much execution risk comes with such a large, complex government rollout. Despite retreating, Salesforce's shares might still be trading above their fair value and there could be some more downside. Discover how much.

Exploring Other Perspectives

CRM 1-Year Stock Price Chart
CRM 1-Year Stock Price Chart
Twenty five Simply Wall St Community fair values cluster between about US$214.76 and US$356.60, reflecting very different expectations. Set against that spread, the VA’s large AI contract sharpens the focus on whether Salesforce can convert marquee wins into sustained, lower risk earnings quality.

Explore 25 other fair value estimates on Salesforce - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Salesforce research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Salesforce research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Salesforce's overall financial health at a glance.

Looking For Alternative Opportunities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

  • Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
  • The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
  • Find 51 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.